Dynavax Technologies reported -0.24 in EPS Earnings Per Share for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Eps Change
Abbvie ABBV:US $ 0K 0K
Adma Biologics ADMA:US -0.13 0.01
Agenus AGEN:US 0.69 1.06
Alexion Pharmaceuticals ALXN:US $ 3.52 0.56
Amgen AMGN:US $ 4.67 0.29
Astrazeneca AZN:US $ 0.54 0.09
AstraZeneca AZN:LN 1.08 0.18
Biogen BIIB:US $ 4.77 0.91
Biomarin Pharmaceutical BMRN:US $ -0.2 0.27
Bristol Myers Squibb BMY:US $ 2 0.07
Chimerix CMRX:US $ -0.21 0
Dynavax Technologies DVAX:US -0.24 0.26
Gilead Sciences GILD:US $ 2.65 0.78
Glaxosmithkline GSK:US $ 1.01 0.22
Gw Pharmaceuticals GWPH:US $ -0.05 0.91
Idera Pharmaceuticals IDRA:US -0.11 0.02
Merk MRK:US $ 1.75 0.44
Minerva Neurosciences NERV:US $ -0.22 0.03
Nektar Therapeutics NKTR:US $ -0.7 0.01
Neurocrine Biosciences NBIX:US $ 0.64 0.21
Novartis NOVN:VX SF 1.71 0.05
Pfizer PFE:US $ 1.34 0.27
Regeneron Pharmaceuticals REGN:US $ 14.37 11.43
Sarepta Therapeutics SRPT:US -0.19 2.11
Tg Therapeutics TGTX:US -0.65 0.06
Vertex Pharmaceuticals VRTX:US $ 3.56 0.45